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Background and aims: Periprocedural analgosedation during transcatheter aortic valve replacement 
(TAVR) has evolved significantly over the past decade. First procedures were done in general anaes-
thesia under the supervision of an anesthesiologist, while recent trends suggest periprocedural anal-
gosedation performed by interventional cardiologists/TAVR operators1. This method often includes 
different medications and protocols, depending on the site-specific preferences. Here we present a 
review of propofol effects along with the protocol utilized at the Catheterization Laboratory (Cath Lab) 
at the University Hospital Centre Split. 
Review and protocol presentation: Our primary used anaesthetic medication is propofol due to its 
beneficial pharmacologic properties including short action and titratable effects leading to effective 
sedation with amnesia, well-being and anti-emesis2. In addition, it shows a good correlation with bis-
pectral index (BIS) allowing for easier titration during longer procedures. However, due to its insuffici-
ent analgesia, we utilize high dose-volumes of local anaesthetic and optionally a systemic bolus-doses 
of fentanyl in selected individuals (Figure 1). To this date, this protocol provided a safe, effective and 
reproducible periprocedural analgosedation during TAVR. Importantly, this protocol was successfully 
performed by the Cath Lab Team, without the need for additional healthcare resources or staff allocati-
on3. To avoid large radiation to the staff, we have also adjusted the equipment (use of long intravenous 
lines; rotation of X-ray tube; monitor orientation) and modified the staff position (Figure 2). 
Conclusions: In conclusion, there are different regimens for periprocedural analgosedation. Periproce-
dural analgosedation with propofol in the bolus-continuous infusion scheme proved to be safe, effec-
tive and reproducible during TAVR. Interventional cardiologists and specialized Cath Lab team are 
trained to provide all aspects of management and care to these patients. 
Figure 1. illustrative overview of propofol plasma concentrations and bispecter index in relation to 
procedural phases (Split protocol).
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Figure 2. Schematic layout of the equipment/staff in the Cath Lab with regard to analgosedation.
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